Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2005
11/08/2005US6962984 IgA nephropathy-related DNA
11/08/2005US6962815 AAV2 vectors and methods
11/08/2005US6962792 cyclin-dependent kinase 4 (CDK4); useful in treatment of tumours and other hyperproliferative disorders
11/08/2005US6962708 Chimeric flavivirus vaccines
11/08/2005US6962698 providing expanded populations of stem cells, as well as progenitor cells, which can be used for hematopoietic cell transplantations, or generation of stem or progenitor cells suitable for genetic manipulations, which may be used for gene therapy
11/08/2005US6962696 Compositions and methods for tumor-targeted delivery of effector molecules
11/08/2005CA2153806C Detection and treatment of mutations in a cd40 ligand gene
11/06/2005CA2504403A1 Prognostic for hematological malignancy
11/03/2005WO2005103716A2 Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
11/03/2005WO2005103713A2 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
11/03/2005WO2005103693A2 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
11/03/2005WO2005103692A2 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
11/03/2005WO2005103291A1 Novel ligand of g-protein-conjugated receptor protein and use thereof
11/03/2005WO2005103288A1 Screening method
11/03/2005WO2005103272A2 Pan cancer oncolytic vectors and methods of use thereof
11/03/2005WO2005103265A1 Multiple heat shock elements
11/03/2005WO2005103259A1 Sars-cov nucleocapsid protein epitopes and uses thereof
11/03/2005WO2005103237A1 Method of constructing recombinant herpes simplex virus
11/03/2005WO2005103078A1 Avian gm-csf
11/03/2005WO2005102395A1 Novel use of aim3 acting as a tumor suppressor
11/03/2005WO2005102383A1 Antigen specific t cell therapy
11/03/2005WO2005102038A2 Expression of polypeptides in rod outer segment membranes
11/03/2005WO2005084307A9 Use of lipid conjugates in the treatment of disease
11/03/2005WO2005059123A3 Pp2a/bgamma subunits, modulators thereof, and their uses in the treatment of mental disorders
11/03/2005WO2005049850A3 Compositions and methods for systemic nucleic acid sequence delivery
11/03/2005WO2005039645A3 Sp1 and sp3 targeted cancer therapies and therapeutics
11/03/2005WO2005020892A3 Pharmaceutical compositions and methods for metabolic modulation
11/03/2005WO2005019433A3 VIRALLY-ENCODED RNAs AS SUBSTRATES, INHIBITORS AND DELIVERY VEHICLES FOR RNAi
11/03/2005WO2004103301A3 Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents
11/03/2005US20050246794 Functional and hyperfunctional siRNA
11/03/2005US20050246566 Process for providing submodel performance in a computer processing unit
11/03/2005US20050245587 Treatment of dyskinesia
11/03/2005US20050245476 Introducing nucleic acid encoding a protein comprising an engineered zinc finger DNA-binding domain
11/03/2005US20050245475 Functional and hyperfunctional siRNA directed against Bcl-2
11/03/2005US20050245474 Double stranded constructs comprising one or more short strands hybridized to a longer strand
11/03/2005US20050245473 Proliferation- and differentiation-modulating agents and uses therefor
11/03/2005US20050245472 Engineered rnai adenovirus silencing expression (erase) of dna reair proteins
11/03/2005US20050245471 Combination products for use in antitumoral treatment
11/03/2005US20050245454 Methods and compositions for impairing multiplication of HIV-1
11/03/2005US20050245450 Method of screening a compound for anxiolytic activity in an apolipoprotein E knockout animal
11/03/2005US20050245446 Materials for the delivery of biologically-active material to cells
11/03/2005US20050244915 Assays for modulators of asparaginyl hydroxylase
11/03/2005US20050244896 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2)
11/03/2005US20050244888 Antibodies to human chemokine beta-9
11/03/2005US20050244877 Splice variants of CD40-receptor
11/03/2005US20050244869 Modulation of transthyretin expression
11/03/2005US20050244859 Cell based assay
11/03/2005US20050244858 Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
11/03/2005US20050244846 MEKK1 proteins and fragments thereof for use in regulating apoptosis
11/03/2005US20050244826 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or wnt
11/03/2005US20050244825 Regulation of human bmp-2 inducible kinase
11/03/2005US20050244817 Mammalian genes involved in viral infection and tumor suppression
11/03/2005US20050244505 Immunotherapy compositions, method of making and method of use thereof
11/03/2005US20050244504 Drug delivery particle; useful in genetic vaccination; eg poly(beta-amino esters)
11/03/2005US20050244483 Film preparation and process for preparing the same
11/03/2005US20050244472 Intraocular drug delivery systems containing excipients with reduced toxicity and related methods
11/03/2005US20050244435 Comprises clostridial neurotoxin light chain domains; endopeptidases; vaccines; fusion proteins; for inhibiting exocytosis
11/03/2005US20050244422 Methods for delivering MBD peptide-linked agent into cells under conditions of cellular stress
11/03/2005US20050244412 Method and composition for regulating activity of regulatory T cells
11/03/2005US20050244410 Toll-like receptor 9 effector agents and uses thereof
11/03/2005US20050244408 gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-IGF-IR antibodies; colorectal or breast cancer tumor
11/03/2005US20050244406 Monoclonal antibodies against extracellular loops of c5ar
11/03/2005US20050244395 Targeted enzyme prodrug therapy
11/03/2005US20050244386 Method of transplanting in a mammal and treating diabetes mellitus by administering a pseudo-islet like aggregate differentiated from a nestin-positive pancreatic stem cell
11/03/2005US20050244381 Adenovirus including a gene coding for a superoxide dismutase
11/03/2005US20050244378 Method for treating glaucoma
11/03/2005US20050244377 Methods of treating cardiac disorders by suppressing the expression of the potassium inwardly-rectifying channel
11/03/2005US20050244376 Modified viral surface proteins for binding to extracellular matrix components
11/03/2005US20050244375 Composition and method of cancer treatment
11/03/2005US20050244374 Enveloped miroorganism
11/03/2005CA2605574A1 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
11/03/2005CA2563741A1 Antisense oligonucleotides against cpla2, compositions and uses thereof
11/03/2005CA2562833A1 Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
11/03/2005CA2561691A1 Method of constructing recombinant herpes simplex virus
11/02/2005EP1591537A2 Hereditary hemochromatosis gene
11/02/2005EP1591530A2 A tumor necrosis factor related ligand
11/02/2005EP1591529A2 Human CLTA-8 and uses of CTLA-8-related proteins
11/02/2005EP1591528A2 Method and compositions for delivery and expression of interferon-alpha nucleic acids
11/02/2005EP1591127A1 REGENERATION AND NEOGENESIS OF RETINAL VISUAL CELL WITH Otx2 GENE
11/02/2005EP1591106A1 Film preparation and process for preparing the same
11/02/2005EP1590468A2 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
11/02/2005EP1590467A1 Use of regulatory sequences for specific, transient expression in neuronal determined cells
11/02/2005EP1590453A2 Custom-made meganuclease and use thereof
11/02/2005EP1590451A2 Alphavirus particles and methods for preparation
11/02/2005EP1590450A2 Recombinant virus production for the manufacturing of vaccines
11/02/2005EP1590443A2 Surface expression of biologically active proteins in bacteria
11/02/2005EP1590438A2 Modified trafficking patterns for arrestin and g-protein-coupled receptors via arrestin-ubiquitin chimera
11/02/2005EP1590372A2 Trimeric polypeptide construct to induce an enduring t cell response
11/02/2005EP1590038A2 Light probe for ultraviolet light activated gene transduction
11/02/2005EP1590002A2 Small interference rna gene therapy
11/02/2005EP1590001A2 Method for in vivo regulation of cardiac muscle contractility
11/02/2005EP1589999A2 Polyvinylethers for delivery of polynucleotides to mammalian cells
11/02/2005EP1589990A2 Method for treating cancer in humans
11/02/2005EP1589943A2 Methods of treating lung diseases
11/02/2005EP1589931A2 RNAi TARGETING OF VIRUSES
11/02/2005EP1421214A4 Amplified oncogenes and their involvement in cancer
11/02/2005EP1233671A4 Compositions and methods for drug delivery using amphiphile binding molecules
11/02/2005EP1168923B1 Dna vaccination for treatment of autoimmune disease
11/02/2005EP1002092B1 Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof
11/02/2005EP0778842B1 Mammalian telomerase
1 ... 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 ... 870